Sarepta Therapeutics (SRPT) Inventory (2016 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Inventory of $1.0 billion for Q1 2026, up 6.34% year-over-year from $941.4 million in Q1 2025, and up 9.44% quarter-over-quarter from $914.7 million in Q4 2025.
Sarepta Therapeutics (SRPT) Inventory (2016 - 2026) Analysis & Trends
Sarepta Therapeutics' Inventory history runs 11 years deep, the most recent figure standing at $1.0 billion for Q1 2026.
- In Q1 2026, Inventory rose 6.34% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $1.0 billion (up 6.34% YoY), while the FY2025 annual figure was $914.7 million, up 21.97% from the prior year.
- Inventory for Q1 2026 stood at $1.0 billion, up from $914.7 million in the prior quarter.
- The five-year high for Inventory was $1.1 billion in Q3 2025, with the low at $199.0 million in Q1 2022.
- The 5-year median for Inventory is $373.5 million (2024), against an average of $525.4 million.
- The sharpest annual moves came in 2022 and 2025: Inventory fell 23.32% in 2022, then jumped 152.04% in 2025.
- Sarepta Therapeutics' Inventory stood at $204.0 million in 2022, then jumped by 58.29% to $322.9 million in 2023, then soared by 132.29% to $750.0 million in 2024, then grew by 21.97% to $914.7 million in 2025, then advanced by 9.44% to $1.0 billion in 2026.
- Business Quant data shows SRPT's Inventory at $1.0 billion in Q1 2026, $914.7 million in Q4 2025, and $1.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | 904.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 904.27 Mn |
| Mar 31, 2026 | 1.00 Bn |
| Dec 31, 2025 | 914.74 Mn |
| Sep 30, 2025 | 1.08 Bn |
| Jun 30, 2025 | 994.04 Mn |
| Mar 31, 2025 | 941.43 Mn |
| Dec 31, 2024 | 749.96 Mn |
| Sep 30, 2024 | 565.92 Mn |
| Jun 30, 2024 | 485.80 Mn |
| Mar 31, 2024 | 373.53 Mn |
| Dec 31, 2023 | 322.86 Mn |
| Sep 30, 2023 | 244.01 Mn |
| Jun 30, 2023 | 226.88 Mn |
| Mar 31, 2023 | 202.68 Mn |
| Dec 31, 2022 | 203.97 Mn |
| Sep 30, 2022 | 221.19 Mn |
| Jun 30, 2022 | 208.10 Mn |
| Mar 31, 2022 | 199.00 Mn |
| Dec 31, 2021 | 186.21 Mn |
| Sep 30, 2021 | 288.47 Mn |